---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-407331"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2026-09-29T20:06:32+00:00"
generated_at: "2026-10-12T13:53:34.796908+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Larimar Therapeutics names John B. Harlow Jr. President and COO; $560K salary, 850K-share equity grant

## Summary
- Harlow, 51, was most recently Chief Commercial Officer at Esperion Therapeutics (Nov 2025-Sep 2026); earlier CCO roles at Melinta Therapeutics, Baudax Bio and Recro Pharma.
- Employment effective September 29, 2026: base salary $560,000 per year, $35,000 cash signing bonus, target annual bonus of 40% of salary (2026 prorated).
- Inducement awards under Nasdaq Rule 5635(c)(4): 800,000 stock options struck at the Sept 29, 2026 closing price and 50,000 restricted stock units.
- Options vest 25% on the first anniversary and the remaining 75% in 36 monthly installments; RSUs vest in four equal annual installments beginning on the first anniversary.
- Severance if terminated without cause: 9 months of salary plus 9 months COBRA; 12 months of salary plus target bonus and COBRA if terminated within one year after a change in control.

## SEC filing metadata
- accession: 0001193125-26-407331
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2026-09-29T20:06:32+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/0001193125-26-407331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/lrmr-20260929.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-407331
- JSON: https://secwatch.observer/filing/0001193125-26-407331.json
- Plain text: https://secwatch.observer/filing/0001193125-26-407331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.